about
Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human geneticsDiagnostic imaging advances in murine models of colitis.Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological TreatmentsA new transcription factor that regulates TNF-alpha gene expression, LITAF, is increased in intestinal tissues from patients with CD and UCPreventive and therapeutic euphol treatment attenuates experimental colitis in miceValidation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug EffectsEffectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.pt.CaM kinase II in colonic smooth muscle contributes to dysmotility in murine DSS-colitis.Effects of an Oral Supplementation of Germinated Barley Foodstuff on Serum CRP Level and Clinical Signs in Patients with Ulcerative Colitis.Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn's diseaseGallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c miceOral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel diseaseThe roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.Hydrolysate from eggshell membrane ameliorates intestinal inflammation in miceSecretory expression of biologically active human Herpes virus interleukin-10 analogues in Escherichia coli via a modified Sec-dependent transporter constructTumor necrosis factor-alpha mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healing.Regulation of gastrointestinal motility by Ca2+/calmodulin-stimulated protein kinase II.Efficacy and safety of adalimumab for the Crohn's disease: a systematic review and meta-analysis of published randomized placebo-controlled trials.Ablation of tumor necrosis factor is associated with decreased inflammation and alterations of the microbiota in a mouse model of inflammatory bowel disease.Antiinflammatory effect of phytosterols in experimental murine colitis model: prevention, induction, remission study.Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice.Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease.Targeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasone.A Picrorhiza kurroa derivative, picroliv, attenuates the development of dextran-sulfate-sodium-induced colitis in miceApoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues.The role of TNFalpha in ulcerative colitis.Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870).Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases.Infliximab therapy for pediatric Crohn's disease.Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone badIxeris dentata NAKAI Reduces Clinical Score and HIF-1 Expression in Experimental Colitis in Mice.Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.Engineering functional epithelium for regenerative medicine and in vitro organ models: a review.Adalimumab for the treatment of Crohn's disease.Specific considerations in the treatment of pediatric inflammatory bowel disease.Oral Administration of Interleukin-10 and Anti-IL-1 Antibody Ameliorates Experimental Intestinal Inflammation.Effect of glucans from Caripia montagnei mushroom on TNBS-induced colitis.Understanding eosinophilic esophagitis: the cellular and molecular mechanisms of an emerging disease.Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis.
P2860
Q21131205-B295BBD4-CBEF-41AB-9F1A-18669ED39E3BQ26774583-E54F30B0-6AEE-4DEE-91AD-6BA52377B653Q26785537-A4B735F9-E792-4181-BF5C-1C867114C7A8Q28248835-963DA24A-BC4E-46C6-8696-8EDD403DA0ADQ28477758-C363CC6C-3335-49EC-B716-E0846F7CDA9DQ28552013-DB9FC95B-A953-4F94-B634-8A7F0E3AD071Q31032345-B439F3A4-9904-4B74-BA98-D287673A503DQ33590606-89A9DB0E-31DC-444D-9927-F77FD3ABB2ABQ34003364-9AA71E67-D5C1-4D24-AB38-224892FEC949Q34449843-05E3DB57-3C7A-4AD4-A414-3FE50CCEB962Q34488647-039C7233-97C1-4237-9FED-98AF9829D992Q34553476-AC350B4D-2BFE-49FB-9203-53B166006EC3Q34623572-E4840AE2-72ED-4B98-9FBE-743A53FE3D86Q34834869-B4D33318-F6F0-439F-B984-DE81609B31E1Q35007984-61F6D638-2D28-4DA0-91DA-F0FC4F7EE5E5Q35088004-983E81C6-DCE3-4020-8A05-2B91BE03A4D2Q35098759-E2BB4C52-A162-4F60-8DDA-19A1703EC8B2Q35177220-05E6BC84-812A-429C-AE40-FAA436C9A1FBQ35182119-26E16C55-A5C3-40E4-BE27-AA4E8CED1AC3Q35288371-972011CA-48B1-4281-BF31-CEE36AECDD02Q35692276-15CF4FD3-0440-4862-A1AC-19AA8BCF811FQ36002746-4E2BBB12-7A3B-4B9F-9439-91E3430220E4Q36142511-1BA05653-15CE-4AA5-9875-8F93B43E394EQ36344230-6FC0C8E1-36C8-410B-B790-F9232BA7A33CQ36587152-869099F8-A487-4076-99E9-446BA468FFC9Q36803301-B871AA11-256B-4289-9726-E74E611660BEQ36849148-4ACB81AF-7AF2-4F7D-BAE9-04CECAB5E311Q36920423-FC56A67C-90D7-4C7D-9085-CB4537D5FE85Q37006166-03B6E44C-D047-430D-92E7-41F6EFF80C8EQ37012073-583895DC-935F-405C-899F-14BF00E8B3A2Q37018335-DB71061D-90F3-4D26-8504-5B46EFC752D8Q37195197-88ADEA19-9FD6-44D9-A718-DB434C883482Q37290683-E11D062D-2AFB-4AD5-8458-44793E6F5068Q37304816-8A54A265-BD25-4ED8-B59F-91F27FA04E1EQ37307855-21FBE2D2-50E9-4241-8ACB-CCC48AD82456Q37345918-55F3E5C7-036C-49A5-98ED-0805D8648A5CQ37358329-A6E5657F-C4C8-445F-8A66-3BB3D84F51D2Q37645197-F1891F01-FD4F-432B-9FE8-131B77586988Q37828058-76DAE8E0-31E4-4136-B19B-3D3BAE0DD7FBQ37847100-706ED3B5-9E1D-430D-AE57-AC8C02D698D5
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Biologic therapy for inflammatory bowel disease.
@ast
Biologic therapy for inflammatory bowel disease.
@en
type
label
Biologic therapy for inflammatory bowel disease.
@ast
Biologic therapy for inflammatory bowel disease.
@en
prefLabel
Biologic therapy for inflammatory bowel disease.
@ast
Biologic therapy for inflammatory bowel disease.
@en
P1433
P1476
Biologic therapy for inflammatory bowel disease
@en
P2093
Gabriele Bianchi Porro
P304
P356
10.2165/00003495-200565160-00002
P577
2005-01-01T00:00:00Z
P6179
1030019196